While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Are you ready for artificial intelligence (AI)-driven mRNA vaccines?

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...